Recent Updates — AGL
Agilon Health reported second quarter 2026 financial results, posting total revenue of $1.49 billion, a 7% increase year-over-year. The company achieved net income of $18 million and Adjusted EBITDA of $70 million, marking significant improvements from the prior year's net loss of $104 million and negative Adjusted EBITDA of $83 million. Management raised full-year 2026 guidance for total revenues to a range of $5.775–$5.86 billion, medical margin to $465–$505 million, and Adjusted EBITDA to $75–$95 million. Agilon Health operates in the healthcare industry, providing value-based care management services and technology platforms for physician groups.
agilon health, inc. announced that Chief Technology Officer Girish Venkatachaliah will terminate his employment effective August 1, 2026. Under a Severance Agreement and General Release, Venkatachaliah will receive $766,063.00 in cash severance paid in installments over twelve months. He will also enter into a Consulting Agreement to provide transition services through December 31, 2026. The agreement includes continued vesting of certain equity awards through April 30, 2027. agilon health, inc. is a healthcare services company.